Skip to main content
Livermore
Livermore
ZHEN

Perceptive Advisors LLC

SEC CIK
0001224962
Latest filing
Aug 14, 2026

Holdings in Q3 2021

Holdings as of Sep 30, 2021, filed Dec 3, 2021. Long positions only; changes compare share counts with Q2 2021.

Institution overview
Positions
138
−10 vs. Q2 2021
Portfolio value
$6.86B
−$827.2M (−10.8%) vs. Q2 2021
Filed
Dec 3, 2021
AmendedSEC
Holdings of Perceptive Advisors LLC in Q3 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
VRCAVerrica Pharmaceuticals Inc.COM3,610,412$45.1M0.7%00.0%UnchangedHistory
NBIXNeurocrine Biosciences IncStock483,007$46.3M0.7%−328,825−40.5%ReducedHistory
BEAMBeam Therapeutics Inc.COM537,635$46.8M0.7%00.0%UnchangedHistory
TVTXTravere Therapeutics, Inc.COM1,965,555$47.7M0.7%+120,000+6.5%AddedHistory
Coherus Biosciences Inc19249HAB9NOTE 1.500% 4/1–$49.4M0.7%–––
MORFMorphic Holding, Inc.COM887,340$50.3M0.7%−50,800−5.4%ReducedHistory
KRONKronos Bio, Inc.COM2,421,142$50.7M0.7%−106,910−4.2%ReducedHistory
NAUTNautilus Biotechnology, Inc.COM8,911,151$54.7M0.8%00.0%UnchangedHistory
ICVXIcosavax, Inc.COM1,922,549$56.9M0.8%+1,922,549NewHistory
RLAYRelay Therapeutics, Inc.COM1,943,097$61.3M0.9%−75,000−3.7%ReducedHistory
PRCTPROCEPT BioRobotics CorpCOM1,656,990$63.2M0.9%+1,656,990NewHistory
RCKTRocket Pharmaceuticals, Inc.COM2,310,261$69.1M1.0%−441,342−16.0%ReducedHistory
ALBOAlbireo Pharma, Inc.COM2,360,139$73.6M1.1%00.0%UnchangedHistory
CHRSCoherus Oncology, Inc.COM4,779,387$76.8M1.1%+81,775+1.7%AddedHistory
RXDXPrometheus Biosciences, Inc.COM3,314,032$78.6M1.1%00.0%UnchangedHistory
AVIRAtea Pharmaceuticals, Inc.COM2,259,224$79.2M1.2%00.0%UnchangedHistory
CRNXCrinetics Pharmaceuticals, Inc.COM3,963,517$83.4M1.2%00.0%UnchangedHistory
ALDXAldeyra Therapeutics, Inc.COM9,903,879$87.0M1.3%00.0%UnchangedHistory
RAPTRAPT Therapeutics, Inc.COM2,907,565$90.3M1.3%+431,905+17.4%AddedHistory
MGTXMeiraGTx Holdings plcCOM6,948,277$91.6M1.3%00.0%UnchangedHistory
OMOutset Medical, Inc.COM1,990,633$98.4M1.4%−396,902−16.6%ReducedHistory
CCCCC4 Therapeutics, Inc.COM STK2,258,566$100.9M1.5%00.0%UnchangedHistory
ZYMEZymeworks Inc.COM3,679,845$106.9M1.6%−625,755−14.5%ReducedHistory
NVTAInvitae CorpCOM3,923,741$111.6M1.6%−895,060−18.6%ReducedHistory
GBTGlobal Blood Therapeutics, Inc.COM4,407,399$112.3M1.6%+254,710+6.1%AddedHistory
ISEEIVERIC bio, Inc.COM7,471,798$121.3M1.8%+2,886,286+62.9%AddedHistory
Nevro Corp64157FAC7NOTE 2.750% 4/0–$126.2M1.8%–––
CERECerevel Therapeutics Holdings, Inc.COM5,086,727$150.1M2.2%+443,632+9.6%AddedHistory
VBIVVBI Vaccines Inc/BCCOM NEW55,042,465$171.2M2.5%00.0%UnchangedHistory
Collegium Pharmaceutical, Inc19459JAA2NOTE 2.625% 2/1–$180.3M2.6%–––
HZNPHorizon Therapeutics Public Ltd CoSHS1,956,940$214.4M3.1%−28,062−1.4%ReducedHistory
LABPLandos Biopharma, Inc.COM14,869,915$217.1M3.2%00.0%UnchangedHistory
FOLDAmicus Therapeutics, Inc.COM26,559,443$253.6M3.7%+3,438,114+14.9%AddedHistory
IOVAIovance Biotherapeutics, Inc.COM11,489,772$283.3M4.1%+530,000+4.8%AddedHistory
SWTXSpringWorks Therapeutics, Inc.COM4,849,912$307.7M4.5%00.0%UnchangedHistory
BBIOBridgeBio Pharma, Inc.COM7,756,928$363.6M5.3%00.0%UnchangedHistory
Retrophin Inc761299AB2NOTE 2.500% 9/1–$454.8M6.6%–––
MRTXMirati Therapeutics, Inc.COM3,387,745$599.3M8.7%+201,847+6.3%AddedHistory

Options (2)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Perceptive Advisors LLC in Q3 2021
SecurityClassPutsCalls
ChemoCentryx, Inc.16383L106COM–$15.8M
FLNAFilana Therapeutics, Inc.COM$6.21M–

Sold out since Q2 2021 (34)

Positions held at the end of Q2 2021 that are gone from this filing.

Positions of Perceptive Advisors LLC sold out since Q2 2021
SecurityClassShares in Q2 2021Value in Q2 2021% of portfolio in Q2 2021History
KDMNKadmon Holdings, Inc.COM15,711,334$60.8M0.8%History
MDTMedtronic plcStock450,000$55.9M0.7%History
DRNADicerna Pharmaceuticals IncCOM800,000$29.9M0.4%History
EXASExact Sciences CorpCOM233,523$29.0M0.4%History
NARIInari Medical, Inc.Stock310,437$29.0M0.4%History
XLRNAcceleron Pharma IncCOM226,760$28.5M0.4%History
RGENRepligen CorpCOM132,500$26.4M0.3%History
ARWRArrowhead Pharmaceuticals, Inc.COM315,141$26.1M0.3%History
COLLCollegium Pharmaceutical, IncCOM978,277$23.1M0.3%History
FBRXForte Biosciences, Inc.COM685,000$23.0M0.3%History
STOKStoke Therapeutics, Inc.COM671,978$22.6M0.3%History
CM Life Sciences II Inc125842203UNIT 02/25/20281,250,000$16.8M0.2%–
Catabasis Pharmaceuticals IN14875P206COM NEW7,687,185$16.2M0.2%–
Therapeutics Acquisition Cor88339T103COM CL A1,500,000$15.4M0.2%–
CVRXCVRx, Inc.COM440,000$12.3M0.2%History
CTMXCytomX Therapeutics, Inc.COM1,640,957$10.4M0.1%History
SILKSilk Road Medical IncCOM147,133$7.04M0.1%History
PRVAPrivia Health Group, Inc.COM135,000$5.99M0.1%History
AKYAAkoya Biosciences, Inc.COM300,000$5.80M0.1%History
BCTG Acquisition Corp05492W103COM500,000$5.69M0.1%–
MREOMereo BioPharma Group plcSPON ADS1,696,068$5.38M0.1%History
Consonance HFW Acquisition CG2445M129UNIT 99/99/9999500,000$5.20M0.1%–
Longview Acquisition Corp. II54319Q204UNIT 99/99/9999500,000$5.04M0.1%–
MRUSMerus N.V.COM175,000$3.69M<0.1%History
AMWLAmerican Well CorpCL A290,000$3.65M<0.1%History
CM Life Sciences Inc18978W109COM CL A227,000$3.18M<0.1%–
GRTXGalera Therapeutics, Inc.COM254,664$2.50M<0.1%History
Cerevel Therapeutics HLDNG I15678U102*W EXP 06/09/202133,066$1.91M<0.1%–
SGTXSigilon Therapeutics, Inc.COM125,000$1.34M<0.1%History
SRRASierra Oncology, Inc.COM NEW66,655$1.30M<0.1%History
SC Health CorpG78516401*W EXP 99/99/999500,000$1.05M<0.1%–
PLXPPLx Pharma Winddown Corp.COM57,459$793.0K<0.1%History
TKNOAlpha Teknova, Inc.COM30,000$712.0K<0.1%History
TCRRTCR2 Therapeutics Inc.COM30,753$505.0K<0.1%History